本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
The acquisition adds high-growth, AI-driven web conversion solutions to Dotdigital's existing customer experience and data platform (CXDP); unlocking cross-sell opportunities and expanding recurring revenue. LONDON, March 4, 2026 /PRNewswire/ -- Dotdigital Group plc (AIM: DOTD), a leading provider of an AI-powered customer experience and data platform (CXDP) for intelligent, personalised marketing at scale, today announces the acquisition of Alia Software Inc. ("Alia"), an AI-powered pop-up and email/SMS list-growth platform built exclusively for merchants on Shopify. The acquisition strengthens Dotdigital's ability to help brands convert anonymous website visitors into known, high-value customers, capturing first- and zero-party data at the very start of the customer journey and activating it across email, SMS and other digital marketing channels. Delivering measurable growth for merchants Alia enables e-commerce brands to drive higher visitor-to-subscriber conversion through intelligent, brand-aligned pop-ups and interactive experiences. Using AI-driven testing and data-based targeting, the platform continuously optimises when and how visitors are engaged, helping merchants grow email and SMS audiences while protecting brand experience. For customers, the combined proposition delivers: Higher conversion rates through AI-optimised on-site engagement Faster audience growth across email and SMS Richer zero-party data capture to power more personalised marketing Improved marketing ROI through better data, targeting and automation Seamless Shopify integration with fast deployment and performance Alia currently serves more than 2,700 customers, holds a 4.7/5 rating on the Shopify App Store, and reached in excess of $8m in annual recurring revenue (ARR) as at 31 December 2025. Strengthening Dotdigital's end-to-end CXDP vision On-site conversion and list growth are central to audience growth strategies, as rising acquisition costs and evolving privacy standards push brands to prioritise owned data. The global lead capture software market is projected to grow from $2.87 billion in 2025 to $4.45 billion by 2029, driven by demand for AI-powered personalisation and automation. By integrating Alia's capabilities into its CXDP through a phased roadmap, Dotdigital will further support customers to: Engage website visitors at the earliest stage of the customer lifecycle and increase signups Enhance cross-channel retargeting opportunities, with smarter use of first and zero-party data Support a scalable owned data strategy Better utilise the Shopify ecosystem by offering one seamlessly integrated tech stack The initial consideration for the acquisition is $30m, with a total maximum consideration of up to $60m dependent upon future performance. Milan Patel, Chief Executive Officer of Dotdigital Group plc, said: "The acquisition of Alia further advances our CXDP vision by strengthening our on-site conversion and zero-party data capture capabilities, helping our customers to build even better engagement with their own customers, which is increasingly critical as marketers navigate rising acquisition costs and evolving privacy standards. Alia's deep Shopify focus and AI-driven optimisation strongly align with our strategy to help customers personalise at scale and drive measurable returns across the entire customer lifecycle. We are delighted to welcome Shaan and the Alia team to the Dotdigital Group." Shaan Arora, Co-Founder and CEO of Alia Software Inc., added: "The earliest moments of the customer journey are fundamental to long-term value creation. By combining our AI-powered on-site conversion technology with Dotdigital's CXDP, merchants can capture richer customer data, improve conversion rates, and build more meaningful customer relationships at scale." A compelling combined benefit for customers and investors The transaction accelerates Dotdigital's product roadmap with best-in-class on-site conversion capability, delivering immediate value to Shopify merchants and creating a clear commercial upside through cross-sell, retention and ARPC expansion. Together, Dotdigital and Alia will provide a more complete, data-driven customer engagement solution, helping brands acquire smarter, personalise deeper and grow faster in a competitive e-commerce landscape. About Dotdigital Dotdigital is a leading provider of AI-powered customer experience and data technology, enabling marketers to deliver personalised communications at scale across multiple digital channels.
SHENZHEN, China, March 4, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in the life sciences, today announced the acquisition of STOmics and CycloneSEQ. It marks a significant milestone in MGI's "SEQALL+GLI+Omics" strategy, positioning the company as the world's only manufacturer of core life science tools spanning short-read sequencing, long-read nanopore sequencing, generative lab intelligence and spatial omics technologies. By bringing spatial biology and nanopore sequencing technologies fully in house, MGI strengthens its product portfolio, enhances long-term competitiveness and advances its vision of becoming a one-stop solution provider for customers' long-read and short-read sequencing needs. Advancing Spatial Multi-Omics with STOmics Established in April 2024, STOmics' proprietary Stereo-seq technology represents a breakthrough in spatial multi-omics, featuring: Large field of view Nano-scale resolution Unbiased whole-transcriptome capture Integrated multi-omics solutions The technology has been widely applied in developmental biology, organ atlas mapping, neuroscience, and digital pathology. To date, Stereo-seq has contributed to more than 60 publications in leading scientific journals, including Cell, Science, Nature, and Cell Research. STOmics' solutions are highly compatible with MGI's patented DNBSEQ sequencing platform, for instance, Stereo-seq libraries are sequenced using MGI's flagship G400 and T7 platforms, ensuring high-quality data output. STOmics related products Following the acquisition, MGI can now offer more accessible, comprehensive, and efficient spatial-temporal omics workflow solutions—empowering researchers with deeper, three-dimensional insights into biological processes. Expanding Long-Read Capabilities with CycloneSEQCycloneSEQ, established in March 2024, has commercialized nanopore sequencing technology as two platforms: G100-ER* for lower throughput and G400-ER* for higher throughput. What is worth mentioning, G100-ER* has obtained CE marking under the European Union's In Vitro Diagnostic Regulation (IVDR), reinforcing its compliance and readiness for regulated markets. CycloneSEQ related products MGI's DNBSEQ technology, which delivers high throughput, high accuracy and cost-effectiveness, naturally complements CycloneSEQ's long-read nanopore sequencing capabilities. Through this integration, MGI will provide users with a comprehensive "long-read + short-read" sequencing toolkit. Delivering a True "SEQALL+GLI+Omics" One-StopBoth STOmics and CycloneSEQ have already maintained close collaboration with MGI, with MGI holding exclusive global distribution licenses for their reagents and products. Upon completion of integration and combination of short-read, long-read and spatial omics under one provider, along with existing generative lab intelligence, MGI significantly enhances customer service capabilities, operational efficiency, and long-term partnership value through the "SEQALL+GLI+Omics" strategy. *This information is for general reference only and does not imply that the relevant product or service will be available in any specific country or region. About MGIMGI Tech Co., Ltd. (or its subsidiaries, together referred to as MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries. Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and has established research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future. Learn more at: https://global-mgitech.com/, LinkedIn, X and YouTube.
SEATTLE and MELBOURNE, Australia, March 3, 2026 /PRNewswire/ -- US BioTek Laboratories, a leading functional laboratory specializing in advanced immunological and integrative diagnostics, today announced the completion of its merger with NutriPATH Pathology, a respected functional pathology laboratory serving integrative and functional medicine practitioners. The merger marks a significant milestone for the global functional laboratory industry. It brings together the two organizations' specialized expertise and a shared commitment to clinical relevance, scientific rigor, and practitioner support. The partnership expands both companies' international footprint while enhancing access to comprehensive, clinically actionable testing for healthcare providers worldwide. US BioTek Laboratories brings decades of experience in immune reactivity, food sensitivity, and specialty biomarker testing, while NutriPATH Pathology is recognized for its expertise in functional pathology, nutritional assessment, and gut health diagnostics. Together, the organizations will offer an expanded portfolio of testing solutions designed to support personalized, root-cause-focused care. Jack Frausing, CEO of US BioTek Laboratories, commented, "This merger marks an exciting new chapter for both US BioTek and NutriPATH. Our shared philosophy centers on providing clinicians with meaningful data they can trust and apply in practice. By bringing our teams and capabilities together, we are strengthening our ability to support practitioners with deeper insights, improved access, and expanded innovation." James Cavaggion, CEO of NutriPATH, alongside Directors Mary Cavaggion and Andrew Cavaggion, shared: "This is more than a combination of two companies — it is a strategic alignment of values, scientific expertise, and a mutual dedication to advancing functional medicine globally." NutriPATH Pathology will continue to operate with its established brand presence in Australia, maintaining continuity for practitioners while gaining access to expanded resources, technologies, and collaborative scientific development. Clients of both organizations can expect a seamless transition and ongoing commitment to service excellence. About US BioTek Laboratories US BioTek Laboratories is a leading functional laboratory dedicated to delivering advanced immunological and specialty testing to integrative, functional, and personalized healthcare providers. Known for its expertise in food sensitivity testing, immune markers, toxin testing, and clinically actionable reporting, US BioTek partners closely with practitioners to support data-driven, patient-centered care. About NutriPATH Pathology NutriPATH Pathology is a trusted functional pathology laboratory based in Australia, providing comprehensive testing solutions across gut health, nutritional status, hormones, and metabolic markers. NutriPATH is widely recognized for its practitioner education, clinical support, and commitment to advancing functional medicine diagnostics. Logo - https://mma.prnasia.com/media2/2923684/US_BioTek_Laboratories_and_NutriPATH_Logo.jpg?p=medium600
IFS Softeon unites Industrial AI and best-in-class warehouse management to deliver unified supply chain excellence from the boardroom to the warehouse floor LONDON, March 3, 2026 /PRNewswire/ -- IFS, the leading provider of Industrial AI software, today announced the completion of its acquisition of Softeon, providing enterprises across manufacturing, logistics and retail access to a new category of supply chain technology. Operating as IFS Softeon, the move brings together IFS's powerful Industrial AI capabilities with Softeon's 20+ years of tier-1 warehouse management software (WMS) expertise. The launch of IFS Softeon marks a defining moment for the supply chain technology landscape, addressing a significant challenge - most enterprises run disconnected ERP and WMS systems, creating costly blind spots. IFS Softeon delivers what no other vendor can match: unified visibility from the boardroom to the warehouse floor, powered by Industrial AI - providing deep industrial domain knowledge, robotics orchestration and proven warehouse execution into a single, seamless offering. IFS Softeon meets growing demand for integrated, intelligent supply chain solutions. IFS already manages $2.4T in critical assets and brings its industry-leading IFS Cloud platform, purpose-built for asset-intensive industries, alongside embedded Industrial AI capabilities and robotics orchestration expertise. IFS Softeon contributes a field-tested WMS platform, Gartner Visionary recognition*, and manages warehouse operations for a blue-chip customer base that includes Brooks, Casey's, Denso, Sears Home Service, Sony, and UPS. Together, IFS Softeon is processing millions of orders per month and managing warehouse operations across 30 countries. Mark Moffat, CEO of IFS, commented: "The introduction of IFS Softeon means every enterprise wrestling with the complexity of modern supply chains now has access to something genuinely new: end-to-end supply chain intelligence, from strategic decision-making to physical execution on the warehouse floor. Industrial AI meets limitless warehouse execution. That's a combination that will supercharge what's possible for our customers." Jim Hoefflin, CEO, IFS Softeon, added: "Joining IFS is the natural next step in Softeon's journey. Our customers chose us because we deliver. Now, backed by IFS's Industrial AI platform and global reach, we can deliver even more - AI-driven warehouse orchestration, robotics interoperability, and predictive inventory intelligence. The future of warehouse management just got a whole lot more exciting." With a shared commitment to operational excellence and customer outcomes, the combined business will accelerate innovation across warehouse automation, inventory optimization and supply chain resilience. Existing Softeon customers will see continued investment and no disruption; existing IFS customers gain access to best-in-class WMS; and new prospects now have the choice of a single vendor for end-to-end supply chain intelligence. *"Magic Quadrant for Warehouse Management Systems", Simon Tunstall, Dwight Klappich, Rishabh Narang, Federica Stufano, 1 May 2025 CONTACT: IFS Press Contacts: EUROPE / MEA / APJ: Adam GillbeIFS, Director of Corporate & Executive CommunicationsEmail: adam.gillbe@ifs.com NORTH AMERICA / LATAM: Mairi MorganIFS, Director of Corporate & Executive CommunicationsEmail: mairi.morgan@ifs.com This information was brought to you by Cision http://news.cision.com The following files are available for download: https://mb.cision.com/Public/855/4315444/afe62e388fd10938_org.jpg IFS Softeon
TORONTO, March 2, 2026 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer in institutional digital asset investment solutions, is pleased to announce the successful closing of the previously disclosed acquisition (the "Transaction") involving Coincheck Group N.V. (the "Purchaser"). The closing of the Transaction occurred on February 28, 2026. The press release of the Purchaser announcing the Transaction, dated January 8, 2026, is available here, and the press release of the Purchaser announcing the closing of the Transaction, dated March 2, 2026, is available here. As a result of the Transaction, the Purchaser indirectly acquired all of the issued and outstanding Class A Common Shares and certain Class B Common Shares of 3iQ Digital Holdings Inc., 3iQ's parent company (the "Parent"), collectively representing approximately 99.81% of the issued and outstanding shares of the Parent and approximately 99.80% of the votes attaching to shares of the Parent. As previously communicated, 3iQ remains a wholly-owned subsidiary of the Parent, as the Parent controls the Purchaser. Consequently, the ultimate beneficial majority ownership of 3iQ remains unchanged, as Monex Group, Inc. owns more than 80% of the issued and outstanding shares of the Purchaser. About 3iQ Digital Asset Management Founded in 2012, 3iQ is one of the world's leading alternative digital asset managers, pioneering institutional-grade investments. 3iQ launched the world's first Digital Assets Managed Account Platform (QMAP), a hedge fund investment solution, offering innovative risk-managed investment solutions to gain exposure to digital assets. 3iQ was also the first to launch a Bitcoin and Ethereum ETP listed on a major global stock exchange, integrate staking into its Ethereum and Solana ETPs boosting investor returns, and offering other regulated ETPs. 3iQ is a subsidiary of Coincheck Group N.V., a NASDAQ-listed holding company based in the Netherlands. Since 2012, 3iQ has been at the forefront of innovation in digital asset investment management. To learn more about 3iQ, visit 3iq.io. W: https://www.3iq.io/ L: https://www.linkedin.com/company/3iq-corp/ X: https://x.com/3iq_corp Media Contacts for 3iQ Europe Angus Campbell Nominis Advisory angus@nominis.co North America Ryan Graham JConnelly +1 862-777-4274 rgraham@jconnelly.com Julie Mercuro JConnelly +1 973-349-6471 jmercuro@jconnelly.com
HOLLYWOOD, Calif., Feb. 27, 2026 /PRNewswire/ -- Netflix, Inc. today announced that it has declined to raise its offer for Warner Bros. Netflix had earlier received notice from Warner Bros. Discovery (WBD) that its Board of Directors has determined Paramount Skydance's (PSKY) latest proposal constitutes a "Superior Proposal" under the terms of WBD's existing merger agreement with Netflix. Netflix issued the following statement in response from co-CEOs Ted Sarandos and Greg Peters: The transaction we negotiated would have created shareholder value with a clear path to regulatory approval. However, we've always been disciplined, and at the price required to match Paramount Skydance's latest offer, the deal is no longer financially attractive, so we are declining to match the Paramount Skydance bid. Warner Bros. is a world-class organization, and we want to thank David Zaslav, Gunnar Wiedenfels, Bruce Campbell, Brad Singer and the WBD Board for running a fair and rigorous process. We believe we would have been strong stewards of Warner Bros.' iconic brands, and that our deal would have strengthened the entertainment industry and preserved and created more production jobs in the U.S. But this transaction was always a 'nice to have' at the right price, not a 'must have' at any price. Netflix's business is healthy, strong and growing organically, powered by our slate and best-in-class streaming service. This year, we'll invest approximately $20 billion in quality films and series and will expand our entertaining offering. Consistent with our capital allocation policy, we'll also resume our share repurchase program. We will continue to do what we've done for more than 20 years as a public company: delight our members, profitably grow our business, and drive long-term shareholder value. About Netflix Netflix is one of the world's leading entertainment services offering TV series, films, games and live programming across a wide variety of genres and languages. Members can play, pause and resume watching as much as they want, anytime, anywhere, and can change their plans at any time. Important Information and Where to Find It In connection with the proposed transaction between Netflix and WBD, WBD filed a definitive proxy statement on Schedule 14A (the "Proxy Statement") with the U.S. Securities and Exchange Commission (the "SEC"). The Proxy Statement was first mailed to WBD stockholders on or around February 17, 2026. Each of Netflix and WBD may also file with or furnish to the SEC other relevant documents regarding the proposed transaction. This communication is not a substitute for the Proxy Statement or any other document that Netflix or WBD may file with the SEC or mail to WBD's stockholders in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS OF NETFLIX AND WBD ARE URGED TO READ THE PROXY STATEMENT, AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE INTO THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION REGARDING NETFLIX, WBD, THE PROPOSED TRANSACTION AND RELATED MATTERS. Investors and security holders may obtain free copies of the Proxy Statement as well as other filings containing information about Netflix and WBD, without charge, at the SEC's website, https://www.sec.gov. The documents filed by Netflix with the SEC also may be obtained free of charge at Netflix's website at https://ir.netflix.net/home/default.aspx. The documents filed by WBD with the SEC also may be obtained free of charge at WBD's website at https://ir.wbd.com. Participants in the Solicitation Netflix, WBD and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of WBD in connection with the proposed transaction under the rules of the SEC. Information about the interests of the directors and executive officers of WBD and other persons who may be deemed to be participants in the solicitation of stockholders of WBD in connection with the proposed transaction and a description of their direct and indirect interests, by security holdings or otherwise, is included in the Proxy Statement, which has been filed by WBD with the SEC. Information about WBD's directors and executive officers is set forth in WBD's proxy statement for its 2025 Annual Meeting of Stockholders on Schedule 14A filed with the SEC on April 23, 2025, WBD's Annual Report on Form 10-K for the year ended December 31, 2024, and any subsequent filings with the SEC. Information about Netflix's directors and executive officers is set forth in Netflix's proxy statement for its 2025 Annual Meeting of Stockholders on Schedule 14A filed with the SEC on April 17, 2025, and any subsequent filings with the SEC. Additional information regarding the direct and indirect interests of those persons and other persons who may be deemed participants in the proposed transaction may be obtained by reading the Proxy Statement regarding the proposed transaction. Free copies of these documents may be obtained as described above. Cautionary Statement Regarding Forward-Looking Statements This document contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on Netflix's and WBD's current expectations, estimates and projections about the expected date of closing of the proposed transaction and the potential benefits thereof, their respective businesses and industries, management's beliefs and certain assumptions made by Netflix and WBD, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "could," "seek," "see," "will," "may," "would," "might," "potentially," "estimate," "continue," "expect," "target," similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control and are not guarantees of future results, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. These and other forward-looking statements, including the failure to consummate the proposed transaction or to make or take any filing or other action required to consummate the transaction on a timely matter or at all, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the completion of the proposed transaction on anticipated terms and timing, including obtaining stockholder and regulatory approvals, completing the separation of WBD's Discovery Global business ("Discovery Global") and Warner Bros. business, anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies, expansion and growth of WBD's and Netflix's businesses and other conditions to the completion of the proposed transaction; (ii) failure to realize the anticipated benefits of the proposed transaction, including as a result of delay in completing the transaction or integrating the businesses of Netflix and WBD; (iii) Netflix's and WBD's ability to implement their business strategies; (iv) consumer viewing trends; (v) potential litigation relating to the proposed transaction that could be instituted against Netflix, WBD or their respective directors; (vi) the risk that disruptions from the proposed transaction will harm Netflix's or WBD's business, including current plans and operations; (vii) the ability of Netflix or WBD to retain and hire key personnel; (viii) potential adverse reactions or changes to business relationships resulting from the announcement, pendency or completion of the proposed transaction; (ix) uncertainty as to the long-term value of Netflix's common stock; (x) legislative, regulatory and economic developments affecting Netflix's and WBD's businesses; (xi) general economic and market developments and conditions; (xii) the evolving legal, regulatory and tax regimes under which Netflix and WBD operate; (xiii) potential business uncertainty, including changes to existing business relationships, during the pendency of the proposed transaction that could affect Netflix's or WBD's financial performance; (xiv) restrictions during the pendency of the proposed transaction that may impact Netflix's or WBD's ability to pursue certain business opportunities or strategic transactions; (xv) failure to receive the approval of the stockholders of WBD; (xvi) the final allocation of indebtedness between WBD and Discovery Global in connection with the separation could cause a reduction to the consideration for the proposed transaction; (xvii) inherent uncertainties involved in the estimates and assumptions used in the preparation of financial projections, and inherent uncertainties involved in the estimates and judgments used to estimate the differences between WBD's Global Linear Networks segment results and the expected results of Discovery Global; and (xviii) volatility or a decline in the market price for Discovery Global common stock following the separation. Discussions of additional risks and uncertainties are contained in Netflix's and WBD's filings with the SEC, including their Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, and the Proxy Statement filed by WBD in connection with the proposed transaction. While the list of factors presented here and in the Proxy Statement are considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Netflix's or WBD's consolidated financial condition, results of operations or liquidity. Neither Netflix nor WBD assumes any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
A12 藝術空間
Acquisitions, mergers, takeovers
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
